Clinical Trial

68Ga-Pentixafor PET/CT Versus Adrenal Vein Sampling in Diagnosing Unilateral Subtype of Primary Aldosteronism Concurrent With Autonomous Cortisol Secretion (PREDICT)

Recruiting
View on ClinicalTrials.gov →
Summary
To validate the accuracy of 68Ga-Pentixafor PET/CT and adrenal venous sampling (AVS) in subtype diagnosis of PA/ACS patients with adrenal nodules, based on biochemical and clinical remission outcomes, and to determine whether the diagnostic accuracy of 68Ga-Pentixafor PET/CT is non-inferior to AVS.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-02-13; most recent amendment 2026-02-03.
Trial Details
NCT Number NCT06833437
Lead Sponsor Qifu Li
Collaborators: The Affiliated Hospital Of Southwest Medical University, Changzhi Medical College, First Affiliated Hospital of Kunming Medical University
Conditions Primary Aldosteronism, Autonomous Cortisol Secretion
Enrollment 178 participants
Start Date 2024-08-01
Primary Completion 2028-12-31 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-05